Publishing research using ab109390? Please let us know so that we can cite the reference in this datasheet.

ab109390 has been referenced in 29 publications.

  • Huang R  et al. Increased Ratio of Global O-GlcNAcylation to Tau Phosphorylation at Thr212 Site Is Associated With Better Memory Function in Patients With Type 2 Diabetes. Front Physiol 10:110 (2019). PubMed: 30837891
  • Chen X  et al. Administration of Repetitive Transcranial Magnetic Stimulation Attenuates Aß1-42-Induced Alzheimer's Disease in Mice by Activating ß-Catenin Signaling. Biomed Res Int 2019:1431760 (2019). PubMed: 30949496
  • Gao L  et al. Exploration of the glutamate-mediated retinal excitotoxic damage: a rat model of retinal neurodegeneration. Int J Ophthalmol 11:1746-1754 (2018). PubMed: 30450303
  • Zheng C  et al. TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone. Front Cell Neurosci 12:485 (2018). PubMed: 30618632
  • Jeong JH & Kang EB Effects of treadmill exercise on PI3K/AKT/GSK-3ß pathway and tau protein in high-fat diet-fed rats. J Exerc Nutrition Biochem 22:9-14 (2018). PubMed: 29673239
  • Shi C  et al. Melatonin Mitigates Kainic Acid-Induced Neuronal Tau Hyperphosphorylation and Memory Deficits through Alleviating ER Stress. Front Mol Neurosci 11:5 (2018). WB ; Mouse . PubMed: 29416502
  • Li H  et al. FTO is involved in Alzheimer's disease by targeting TSC1-mTOR-Tau signaling. Biochem Biophys Res Commun 498:234-239 (2018). WB . PubMed: 29501742
  • Tang Y  et al. Estrogen-related receptor alpha is involved in Alzheimer's disease-like pathology. Exp Neurol 305:89-96 (2018). PubMed: 29641978
  • Pu D  et al. Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity. Neuroscience 381:35-45 (2018). WB, IHC-P ; Mouse . PubMed: 29684505
  • Zhang F  et al. Impacts of Acute Hypoxia on Alzheimer's Disease-Like Pathologies in APPswe/PS1dE9 Mice and Their Wild Type Littermates. Front Neurosci 12:314 (2018). PubMed: 29867325
  • Li H  et al. Defect of branched-chain amino acid metabolism promotes the development of Alzheimer's disease by targeting the mTOR signaling. Biosci Rep 38:N/A (2018). PubMed: 29802157
  • Yang Y  et al. Fuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau Hyperphosphorylation. Evid Based Complement Alternat Med 2017:5934254 (2017). PubMed: 29422936
  • Wang T  et al. Involvement of Insulin Signaling Disturbances in Bisphenol A-Induced Alzheimer's Disease-like Neurotoxicity. Sci Rep 7:7497 (2017). PubMed: 28790390
  • Albayram O  et al. Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae. Nat Commun 8:1000 (2017). PubMed: 29042562
  • Bou Samra E  et al. A role for Tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival. Nat Commun 8:693 (2017). PubMed: 28947735
  • Ibáñez-Salazar A  et al. Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts. Front Neurosci 11:495 (2017). PubMed: 28936161
  • Branca C  et al. Dyrk1 inhibition improves Alzheimer's disease-like pathology. Aging Cell 16:1146-1154 (2017). PubMed: 28779511
  • Tong M  et al. T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease. J Alzheimers Dis 51:123-38 (2016). PubMed: 26836193
  • Uekawa K  et al. Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis 53:127-33 (2016). PubMed: 27128367
  • Stefanova NA  et al. An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology. Aging (Albany NY) 8:2713-2733 (2016). PubMed: 27750209
  • Sadick JS  et al. Protein characterization of intracellular target-sorted, formalin-fixed cell subpopulations. Sci Rep 6:33999 (2016). WB, ICC/IF ; Human . PubMed: 27666089
  • Guo C  et al. Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model. Sci Rep 6:29396 (2016). PubMed: 27406855
  • Tan Y  et al. 7,8-Dihydroxyflavone Ameliorates Cognitive Impairment by Inhibiting Expression of Tau Pathology in ApoE-Knockout Mice. Front Aging Neurosci 8:287 (2016). WB ; Mouse . PubMed: 27965573
  • Choi WH  et al. Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. Nat Commun 7:10963 (2016). PubMed: 26957043
  • Kim D  et al. Identification of disulfide cross-linked tau dimer responsible for tau propagation. Sci Rep 5:15231 (2015). ICC/IF . PubMed: 26470054
  • Ma DL  et al. Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice. J Neurochem 135:301-8 (2015). PubMed: 26183127
  • Han DH  et al. Direct cellular delivery of human proteasomes to delay tau aggregation. Nat Commun 5:5633 (2014). PubMed: 25476420
  • Manczak M & Reddy PH Abnormal interaction of oligomeric amyloid-ß with phosphorylated tau: implications to synaptic dysfunction and neuronal damage. J Alzheimers Dis 36:285-95 (2013). IP, WB ; Human . PubMed: 23594602
  • Murakami K  et al. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid ß protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 286:44557-68 (2011). WB . PubMed: 22072713

For licensing inquiries, please contact

Sign up